Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07148778

Effectiveness of Chatbot-Supported Web Program in Postpartum Care

The purpose of this clinical study was to evaluate the effectiveness of a web-based "Postpartum Care Package" program developed for postpartum women and delivered via a chatbot, and to examine its effects on the postpartum health of mothers and newborns.

The key questions it aims to answer are:

* What is the impact of the chatbot-supported web-based "Postpartum Care Package" program on the postpartum health of mothers and newborns? * Does the chatbot-supported web-based "Postpartum Care Package" program increase women's accessibility and availability of postpartum care resources?

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Age range

18 year–35 year

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Women who will be included in the study.

  • Have given birth between the 37th and 41st weeks of pregnancy,
  • Be primigravida,
  • Have not been diagnosed with a high-risk pregnancy,
  • Have an educational level of primary school or above,
  • Have no communication difficulties or mental disabilities,
  • Have access to equipment (mobile phone, computer, tablet, internet) for web-based education,
  • Have experienced no complications in the mother or baby during pregnancy, childbirth, or the postpartum period,
  • Voluntarily agree to participate in the study,

Exclusion criteria

  • Women who moved outside the province where the study was conducted during the implementation period,
  • Women who voluntarily withdrew from the study,
  • Women who did not participate in any phase of the study will not be included in the study.

Treatment and study plan

Educational intervention

Behavioral

In this study, a web-based postpartum care package program supported by a chatbot will be administered to the intervention group.

A pre-test will be administered to participants in the intervention group within 24-48 hours after birth.

Participants in this group will be informed that they must watch the videos in the educational modules until the sixth week postpartum. Reminder messages will also be sent to participants via the website, email, and phone calls (between days 7 and 14 postpartum and week 3 postpartum). Participants who have completed the module training will be eligible for post-tests at 6 weeks postpartum and 3 months postpartum.

Primary outcomes

  1. Postpartum Physical Symptom Severity Scale

    Time frame: Pre-test/24-48 hours postpartum Post-test/6 weeks and 3 months postpartum

    Maternal physical health will be assessed using the Postpartum Physical Symptom Severity Scale. This four-point Likert-type scale ranges from 0 to 54, with higher scores indicating greater severity of postpartum physical symptoms.

  2. Visual Analog Scale

    Time frame: Pre-test/24-48 hours postpartum Post-test/6 weeks and 3 months postpartum

    Mothers' physical discomfort/pain levels will be assessed using a Visual Analog Scale. The scale consists of a 10 cm horizontal line, where "0" represents no discomfort and "10" represents the most severe discomfort imaginable. Participants will be asked to mark the point on the line that best reflects their level of physical discomfort/pain during the assessment. Higher scores indicate more severe discomfort/pain.

  3. Edinburgh Postpartum Depression Scale

    Time frame: Pre-test/24-48 hours postpartum Post-test/6 weeks and 3 months postpartum

    The Edinburgh Postnatal Depression Scale will be used to screen for depressive symptoms in postpartum women. The scale consists of 10 items on a four-point Likert-type scale. Each item is scored from 0 to 3, and the total score ranges from 0 to 30. Higher scores indicate more depressive symptoms.

  4. Sexual Life Quality Scale

    Time frame: Pre-test/24-48 hours postpartum Post-test/6 weeks and 3 months postpartum

    The Sexual Quality of Life Scale will be used to evaluate the impact of sexual functions on the quality of life of individuals. It assesses physical, emotional, and relational aspects of sexual well-being. This Likert-type scale consists of 18 items. Higher scores reflect better sexual quality of life, while lower scores indicate deterioration in sexual well-being.

  5. Breastfeeding Self-Efficacy Scale

    Time frame: Pre-test/24-48 hours postpartum Post-test/6 weeks and 3 months postpartum

    The Breastfeeding Self-Efficacy Scale will be used to assess mothers' levels of breastfeeding self-efficacy. It evaluates maternal perceptions regarding their skills, knowledge, and coping abilities related to breastfeeding. The scale consists of 14 items rated on a five-point Likert scale. Scores range from 14 to 70, with higher scores indicating greater breastfeeding self-efficacy.

Secondary outcomes

  1. Postpartum care package program satisfaction

    Time frame: 3rd month postpartum

    Participants' satisfaction level with the Chatbot-supported web-based Postpartum Care Package program will be measured with a 5-point Likert-type satisfaction survey.

Study contacts

Contact information is provided by the study sponsor or research team.

Emine ILKIN AYDIN, Lecturer

CONTACT

[email protected]

+905456281694

Sponsors and collaborators

Lead sponsor

Emine Ilkin Aydin

Other

Registry information

Official study title

Evaluation of the Effectiveness of a Chatbot-Supported Web-Based Postpartum Care Package Program for Postpartum Women

Important dates

Study start
2025
Primary completion
2026
Study completion
2026
First posted
Aug 29, 2025
Registry last updated
Aug 29, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.